SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 348 filers reported holding SEATTLE GENETICS INC in Q1 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $91,384,000 | -10.2% | 466,983 | -22.0% | 0.80% | -11.3% |
Q2 2020 | $101,740,000 | +5.9% | 598,751 | -28.1% | 0.90% | -16.7% |
Q1 2020 | $96,117,000 | -20.3% | 833,050 | -21.0% | 1.08% | +21.3% |
Q4 2019 | $120,539,000 | +29.2% | 1,054,953 | -3.4% | 0.89% | +21.8% |
Q3 2019 | $93,295,000 | +109.6% | 1,092,445 | +69.8% | 0.73% | +117.6% |
Q2 2019 | $44,516,000 | -51.7% | 643,204 | -48.9% | 0.34% | -48.7% |
Q1 2019 | $92,147,000 | +39.4% | 1,258,153 | +7.8% | 0.66% | +22.7% |
Q4 2018 | $66,120,000 | +666.9% | 1,166,968 | +943.8% | 0.53% | +853.6% |
Q3 2018 | $8,622,000 | +119.2% | 111,795 | +88.6% | 0.06% | +100.0% |
Q2 2018 | $3,934,000 | +1729.8% | 59,263 | +923.7% | 0.03% | +1300.0% |
Q3 2014 | $215,000 | -5.3% | 5,789 | -2.5% | 0.00% | 0.0% |
Q2 2014 | $227,000 | -17.5% | 5,938 | -1.8% | 0.00% | 0.0% |
Q1 2014 | $275,000 | -9.8% | 6,046 | -20.9% | 0.00% | 0.0% |
Q4 2013 | $305,000 | -93.8% | 7,646 | -93.2% | 0.00% | -94.7% |
Q3 2013 | $4,922,000 | -82.6% | 112,290 | -87.5% | 0.04% | -83.9% |
Q2 2013 | $28,338,000 | – | 900,768 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |